Related by context. All words. (Click for frequent words.) 68 developing TB4 66 Currently RegeneRx 65 orally bioavailable 64 sodium glucose cotransporter 64 synthetic peptide 64 selectively inhibits 64 humanized monoclonal antibody 64 Myolimus 64 intranasal formulation 63 anti secretory 63 antisense drug 63 orally administered inhibitor 63 2 methoxyestradiol 63 TÎ ² 4 63 PDE4 inhibitor 62 Cathepsin S 62 injectable formulation 62 Enkephalin 62 selective antagonist 62 Nanobody 62 IMiDs R 62 MTP inhibitor 62 receptor partial agonist 61 proteasome inhibitor 61 IAP inhibitor 61 polymerase inhibitor 61 novel orally administered 61 Pathway Inhibitor 61 peripherally acting 61 chemically modified siRNA 61 MEK inhibitor 61 ADP receptor antagonist 61 highly selective inhibitor 61 small molecule thrombopoietin 61 Sym# 61 targeted radiotherapeutic 61 Guanilib 61 antisense inhibitor 61 ATL# [002] 60 Alfacell proprietary ribonuclease 60 receptor modulators 60 selective agonist 60 Chemokine Receptor 60 GAD# 60 IMiDs ® 60 PNP inhibitor 60 Liposomal 60 Cyclooxygenase Inhibiting Nitric Oxide 60 prodrugs 60 MKC# MKC# PP 60 liposomal formulation 60 Elvitegravir 60 renin inhibitors 60 carbohydrate polymer 60 peptibody 60 drug ISA# 60 CEQ# 60 Janus kinase 60 humanized anti 60 PORxin TM 60 anionic backbone 60 Preclinical studies suggest 60 melanocortin receptor agonists 60 Thrombin topical Recombinant 60 pan HDAC inhibitor 60 enzyme inhibitor 60 IAP inhibitors 60 antisense oligonucleotide 60 prostones 60 AEG# 59 immunomodulator 59 RNA antagonist 59 Aganocide 59 highly selective endothelin 59 NTDDS 59 VEGF receptor 59 SAR# [002] 59 taxane derivative 59 PORxin 59 ENMD # 59 selective androgen receptor modulator 59 AAG geldanamycin analog 59 histone deacetylase HDAC inhibitors 59 cyclin dependent kinase inhibitor 59 Chrysalin 59 small molecule modulators 59 vinca alkaloid 59 novel immunomodulatory 59 rxRNA 59 immune stimulatory 59 AtuRNAi 59 delta opioid receptor 59 Nanobody ® 59 humanized monoclonal 59 selective inhibitor 59 HepDirect prodrug 59 chimeric monoclonal antibody 59 nitric oxide donating 59 defensin mimetic antibiotic 59 geldanamycin 59 RECOTHROM ® 59 treat male hypogonadism 59 Nanobodies 59 XmAb ™ 59 macrocycles 59 VEGF receptors 59 acting muscarinic antagonist 59 liposomal delivery 59 JAK inhibitors 59 MEK inhibitors 59 PEGylated 59 RNAi therapeutic targeting 59 peptide conjugated 59 nucleoside analog 59 selectively inhibit 59 small molecule glucokinase 59 protein tyrosine phosphatase 1B 59 SMARTICLES ® 59 small molecule inhibitor 59 nucleoside analogues 59 tiapamil 58 oncolytic 58 alkylating 58 methylnaltrexone bromide 58 TLR8 58 BRAF kinase 58 siRNAs targeting 58 orally bioavailable mimics 58 coupled receptors GPCRs 58 vascular disrupting agents 58 non nucleoside HCV 58 selective orally bioavailable 58 G Protein Coupled 58 inhaled formulation 58 targeting CD# 58 hypoxia inducible factor 58 Panzem R 58 antagomirs 58 receptor agonist 58 C5aR 58 ProLindac TM 58 histone deacetylase HDAC 58 IMiD 58 novel peptide 58 orally dosed 58 ospemifene 58 LNPs 58 selective androgen receptor modulators 58 anticancer compound 58 naturally occurring neuroprotective 58 small molecule activators 58 E2F 58 compound PMX # 58 histone deacetylase 58 Voreloxin 58 Locked Nucleic Acid 58 active moiety 58 HSP# inhibitor 58 synthetic peptides 58 anti CD3 monoclonal 58 peroxisome proliferator activated 58 cathepsin K inhibitor 58 antibody fragment 58 Squalamine 58 Anticalins 58 peptidic compound 58 aurora kinase 58 candidate deforolimus 58 POTELLIGENT ® 58 investigational pan BCR 58 Nabi HB ® 58 proteasome inhibitors 58 ALN TTR 58 proprietary MSCRAMM ® 58 non nucleoside inhibitor 58 multi kinase inhibitor 58 INxin TM 58 recombinant fusion 58 potent inhibitors 58 PI3K inhibitor 58 recombinant subunit vaccine 58 GelSite R polymer 58 JAK inhibitor 58 cyclic peptide 58 Onconase 58 receptor antagonists 58 Spiegelmer 58 investigational compounds 58 Hsp# inhibitors 57 polymerase inhibitors 57 oral prodrug 57 JAK1 57 COMPLEGENT TM Technologies 57 non nucleoside 57 sodium thiosulfate STS 57 BMS # 57 Thymosin beta 4 57 products Oncaspar 57 HCV NS3 protease 57 selective kinase inhibitor 57 Omacetaxine 57 activate SIRT1 57 siRNA therapeutics 57 acyclovir Lauriad R 57 potent inhibitor 57 mimetics 57 epothilones 57 Janus Kinase 57 Mipomersen 57 agonist compounds 57 oral dual endothelin 57 antifolate 57 TLR9 agonist 57 metaglidasen 57 phosphate S1P 57 protein kinase inhibitor 57 PRLX # 57 catalytic antioxidant compounds 57 selective relaxant 57 peptidomimetic 57 partial agonist 57 siRNA therapeutic 57 beta lactam 57 anti aging glycopeptides 57 Angiocept 57 Tyrima 57 oxazolidinone 57 angiogenesis inhibitor 57 Belerofon 57 therapeutic monoclonal antibodies 57 neuroprotective properties 57 epothilone 57 CORT # 57 anti amnesic 57 selective inhibition 57 TRAIL receptor 57 reversible inhibitor 57 reversible inhibitors 57 DepoVax ™ 57 serine protease 57 biased ligand 57 THR beta agonist 57 small molecule inhibitors 57 antisense compounds 57 anticancer compounds 57 novel VDA molecule 57 novel synthetic peptide 57 MT#/MEDI-# 57 lipid nanoparticle 57 resolvin 57 Elesclomol 57 mTOR mammalian target 57 peptide antigens 57 HDACi 57 HuCAL antibody 57 Sudhir Agrawal D.Phil 57 selective inhibitors 57 EZN 57 investigational monoclonal antibody 57 TG# [003] 57 OMP #M# 57 clinically validated targets 57 histone deacetylase HDAC inhibitor 57 TRC# 57 Anticalins R 56 AKT inhibitor 56 muscarinic receptor agonist 56 PROfusion 56 synthetic retinoid 56 proprietary Dicer Substrate Technology 56 BT VACC TM 56 polysaccharide polymer 56 targeted antifolate 56 prostone 56 kidney urologic 56 Thiarabine 56 ALN TTR# 56 Spiegelmer ® 56 thrombin receptor 56 Pancreate 56 Onalta 56 CYT# potent vascular disrupting 56 Locked Nucleic Acid LNA 56 MT# MEDI 56 mitiglinide 56 5 HT2A serotonin 56 investigational humanized monoclonal antibody 56 Carfilzomib 56 Personalized Immunotherapy 56 HCV protease 56 PSN# [002] 56 RAF kinase 56 stable nucleic acid 56 DOS# 56 MVA BN R 56 CB2 selective receptor agonist 56 vaccine GRNVAC1 56 histone deacetylase inhibitors 56 GRNVAC1 56 A3 adenosine receptor 56 generation antisense 56 product platforms AZX# 56 Augment TM 56 NNRs 56 immunomodulatory 56 virosome 56 kinase inhibitor 56 Bucindolol 56 SARMs 56 Olaparib 56 topically applied SEPA 56 POTELLIGENT R 56 Diamyd ® 56 nicotinic acetylcholine receptor 56 PKC# 56 subtype selective 56 oral antiviral 56 potently inhibit 56 thyroid hormone receptor 56 siRNA sequences 56 cardio renal 56 fusion inhibitors 56 Anidulafungin 56 receptor antagonist 56 SGLT2 56 anticancer agent 56 dipeptidyl peptidase IV 56 RECOTHROM R 56 thrombopoietin 56 novel histone deacetylase 56 Viprovex TM 56 Lixivaptan 56 selective immunoproteasome inhibitor 56 sulfonylhydrazine class 56 AAV vector carrying 56 FOLOTYN ® 56 humanized antibodies 56 RNA antagonists 56 selective modulator 56 IMiDs ® compound 56 5 HT2A inverse 56 investigational drug 56 myelofibrosis polycythemia vera 56 5 HT4 56 CCX# 56 therapeutic monoclonal antibody 56 receptor modulator 56 siRNA delivery 56 5 HT6 receptor 56 Tβ4 56 Aurora kinase 56 mda 7 56 sphingosine 1 56 ALVESCO ® 56 RiVax 56 mTOR inhibitor 56 sigma receptors 56 kinase PI3K 56 glucagon receptor 56 #ME# 56 Archexin 56 inhibits protein synthesis 56 humanized monoclonal antibodies 56 insulin sensitizer 56 anticancer therapeutics 56 Cannabinor 56 Onalta TM 56 signal transduction inhibitor 56 Factor VIIa 56 GTC recombinant form 56 anti angiogenic agent 55 valtorcitabine 55 nicotinic alpha 7 55 anticoagulant reversing agent 55 IRX 2 55 mertansine 55 PI3K/Akt pathway inhibitor 55 phosphoinositide 3 55 PORxin TM platforms 55 chemokine 55 SGLT inhibitors 55 vascular disrupting agent 55 Cethrin R 55 OXIGON 55 NAGS deficiency 55 neuronal nicotinic receptors NNRs 55 induces apoptosis 55 Nutra Pharma wholly owned 55 BAY #-# 55 mitogen activated ERK kinase 55 Acellular Pertussis Vaccine Adsorbed 55 personalized cellular immunotherapy 55 Sapacitabine 55 sodium glucose transporter 55 RONDEL ™ 55 HDAC inhibitor 55 novel prodrug 55 ADCC enhanced 55 acetylcholinesterase 55 ALN PCS 55 5 HT2A receptor 55 recombinant protein 55 immune modulatory 55 non porcine pancreatic 55 prostanoid 55 inhibitor PPI 55 agonist 55 CD# monoclonal antibody 55 BCR ABL inhibitors 55 immune modulator 55 oxidative stress inducer 55 SGLT Inhibitors 55 Micro Incubation System 55 HQK 55 PDE4 55 immunotherapeutic vaccine 55 cyclophilin inhibitors 55 novel orally bioavailable 55 AzaSite Xtra 55 peptide 55 Lauriad R 55 novel peptides 55 #HT#A 55 nitric oxide donating prostaglandin 55 SGLT2 inhibitors 55 PDE# 55 GPCR targets 55 DNA plasmids 55 Tarmogen 55 Tasimelteon 55 polymer conjugate technology 55 ABILIFY ® 55 cytotoxin 55 covering SNALP 55 polyketides 55 Nasdaq OMER 55 Anticalin 55 adenoviral 55 orally administered 55 small molecule defensin 55 seliciclib CYC# 55 oral immunomodulatory 55 microtubule inhibitor 55 GelSite ® 55 Annamycin 55 Novosom 55 Maribavir 55 Phase IIb clinical trials 55 hormone LHRH antagonist 55 Talabostat 55 adrenergic regulation 55 Fragile X mental retardation 55 nucleoside 55 M2 subunit 55 investigational compound 55 Genasense ® oblimersen 55 XmAb ® 55 receptor agonists 55 retinoid X 55 Adnectin 55 humanized antibody 55 Protein Kinase C 55 peptidic 55 RiVax ™ 55 small molecule activator 55 telomerase therapeutic 55 Gentamicin Surgical Implant 55 metabotropic glutamate receptor 54 triggers apoptosis programmed 54 NS5A 54 adenosine A2A 54 pralatrexate injection folate analogue 54 LEX System 54 Aganocide ® 54 neuropathic pain metabolic diseases 54 JAK2 inhibitor 54 Factor NGF 54 mitotic kinesin 54 molecular imaging radiopharmaceutical 54 enhance ApoA 54 Epothilones 54 adenosine receptor 54 Vascular Wrap TM 54 metalloenzymes 54 reformulates existing FDA 54 oral Factor Xa 54 CB2 receptor 54 ASC J9 54 MDRNA proprietary 54 TRV# [001] 54 receptor subtype 54 Hsp# inhibitor 54 CTAP# Capsules 54 DNA RNA Medicines 54 JAK#/JAK# 54 immunotherapeutic 54 PI3K inhibitors 54 Fc fusion protein 54 Teplizumab 54 Litx 54 PARP inhibitor 54 HGS# 54 deacetylase inhibitors 54 histone deacetylase inhibitor 54 Nanobodies ® 54 Anticalins ® 54 EHT AGN 54 JAK3 54 IgG1 antibody 54 Tarvacin TM 54 tyrosine kinase inhibitor 54 serotonin receptor 54 BHT DNA 54 reslizumab 54 cyclophilin inhibitor 54 acetylcholinesterase AChE 54 Vaccinex 54 Symadex 54 romazarit 54 Nventa proprietary CoVal 54 Tobira Therapeutics 54 synthetic anti infective 54 Adnectins 54 KSP inhibitor 54 ESBA# 54 Synavive 54 #HT# 54 brain penetrant 54 Sphingomab 54 recombinant polyclonal antibodies 54 Debio 54 preclinically 54 Homspera TM 54 ARRY # 54 Daclizumab 54 TLR9 54 gallium containing 54 adrenal steroid hormones 54 Selective Electrochemical Tumor Ablation 54 gastro intestinal inflammation 54 aptamer 54 PDGF receptor 54 immunomodulators 54 topical anti infective 54 dAbs 54 vitro pharmacology 54 cyclin dependent kinases 54 GelVac TM 54 glycosylated 54 radiation sensitizer 54 PTP 1B 54 YONDELIS R 54 Propofol IDD D 54 Roche SWX ROG 54 liposome encapsulated 54 telomerase activators 54 immune modulators 54 KL4 Surfactant 54 human antibody therapeutics 54 nasal calcitonin product 54 Modified Vaccinia Ankara MVA 54 XmAb TM 54 NeuroSTAT ® 54 PEGylation technology 54 PRT# 54 S#P# 54 GMX# 54 Advanced Ambrotose 54 HuCAL PLATINUM ® CysDisplay 54 ancrod 54 CB2 selective 54 DiLA2 54 CTLA4 Ig 54 OXIGON TM 54 Oral NKTR 54 Fludara ® 54 Receptos 54 protein tyrosine phosphatases 54 Quark Biotech 54 utilizes InSite Vision 54 5 HT4 receptor 54 antisense oligonucleotides 54 Smac mimetics 54 GAMMAGARD 54 buccal soluble film 54 Vidofludimus 54 TNF receptors 54 vidofludimus 54 Tß4 54 anti CD3 54 potently inhibited 54 bacterial enzyme 54 Viprovex R 54 valent conjugate vaccine 54 Pertuzumab 54 OvaRex ® MAb 54 peptide therapeutics 54 REGENERX BIOPHARMACEUTICALS INC. 54 poly ADP ribose polymerase 54 TLR9 agonists 54 oral Janus kinase 54 proprietary LNA 54 topoisomerase 54 Vitamin D analogue 54 proprietary MSCRAMM R 54 NanoStat 54 small molecule 54 mu opioid receptor antagonist 54 SMaRT ™ 54 monoclonal 54 liposomal 54 poly ethylene glycol PEG 53 IIB ActRIIB 53 cholesteryl ester transfer 53 Zalypsis 53 SERMs 53 epigenetic enzymes 53 Proellex TM 53 microRNA therapeutics 53 prolyl hydroxylase inhibitors 53 protein kinases 53 CEROVIVE NXY 53 GelSite polymer 53 otelixizumab 53 dasatinib Sprycel 53 prodrug 53 patented Bioral 53 RenaZorb TM 53 fusion proteins 53 platinum chemotherapeutic 53 TRANSDUR ™ 53 immunotoxin 53 Nautilus Biotech 53 acetonide FA 53 including eniluracil ADH 53 ribonuclease 53 Sphingomab TM 53 c Raf kinase 53 Vegenics 53 PharmaNova 53 anti fibrotic 53 ALK inhibitor 53 NanoTab 53 Luveris R Ovidrel R 53 mGluR5 antagonists 53 PI3K/mTOR 53 melanocyte stimulating hormone 53 Maxy G# 53 Drug Eluting Stent System 53 ChromeMate 53 antitumoral 53 Nippon Shinyaku 53 molecular imaging radiopharmaceuticals 53 alpha#beta# 53 systemic RNAi therapeutic 53 vanilloid receptor 53 novel anticancer 53 CYC# 53 NEUGENE antisense 53 Abeta# 53 MLN# 53 DHFR 53 cortisol synthesis 53 polyketide 53 aptamer therapeutics 53 chemical entities NCEs 53 HDACs 53 tubulin binding 53 Myocet 53 targets Galectin receptors 53 RONDEL TM 53 CD# CEA 53 factor receptor FGFR 53 Accelerated Intelligent 53 proven DuraSite ® 53 R roscovitine 53 Gonal f R 53 protein kinase inhibitors 53 Prednisporin 53 antisense drugs 53 echinocandins 53 immune modulation 53 imatinib Gleevec ® 53 Curaxins 53 ionotropic glutamate receptor antagonists 53 gamma secretase inhibitors 53 Receptors GPCRs 53 Vorinostat 53 immunomodulating 53 CK # novel 53 MolecularBreeding TM 53 XmAb# 53 bioadhesive polymer core 53 adult mesenchymal stem 53 drug conjugate ADC 53 engineered RAP peptides 53 estrogen receptor beta 53 exon skipping 53 synthetic siRNA 53 commercialize OncoGenex lead 53 Erimos 53 Affitech AS 53 hypoxia activated prodrug 53 allosteric modulator 53 small molecule agonists 53 novel antiviral therapeutics 53 RiVax TM 53 EndoTAG TM 53 DiLA 2 53 urate oxidase 53 MET VEGFR2 53 immunotoxins 53 maytansinoid 53 therapeutic mAbs 53 ddRNAi 53 Affimed Therapeutics AG 53 Cyclosert TM 53 c MET 53 Crucell PER.C6 ® 53 bioconjugation 53 mTOR inhibitors 53 preclinical efficacy 53 CCR9 antagonist 53 anticancer agents 53 HuMax TAC 53 Galectin 53 TELINTRA 53 kinase inhibition 53 generation purine nucleoside 53 BiTE 53 DsiRNA 52 attach auristatin 52 BiTE antibody 52 antimitotic 52 bortezomib Velcade 52 tyrosine kinase inhibitor TKI 52 PF # [002] 52 renin inhibitor 52 oral probiotic 52 secretase 52 human monoclonal antibody 52 Valortim TM 52 HCV protease inhibitor 52 brivanib 52 MGd 52 preclinical compounds 52 P#X# 52 immune modulating 52 TRANSDUR ® 52 Fleximer 52 antibody therapeutics 52 accumulate preferentially 52 Etubics 52 ErbB3 52 HuLuc# 52 NP2 Enkephalin 52 cancer immunotherapies 52 XmAb 52 tranilast 52 photosensitizer 52 acne impetigo 52 Six3 52 camptothecin 52 stromal cells MSCs 52 ProNAi 52 gamma secretase inhibitor 52 ENaC 52 CYT# novel 52 novel antibody therapeutics 52 chemotherapeutic agent 52 Vascular Endothelial Growth 52 enzyme inhibitors 52 anti mitotic 52 theranostic 52 potent anticancer 52 ProEthic Pharmaceuticals 52 morpholino 52 induce apoptosis 52 ELADUR ™ 52 HyACT 52 iPSC technology 52 SGLT 2 52 neuronal nicotinic receptor NNR 52 Nanobody R 52 Micromet BiTE 52 Affibody 52 Friedreich Ataxia FRDA 52 bioabsorbable polymer 52 Stapled Peptide 52 Miraxion Amarin lead 52 Hedgehog signaling pathway 52 Tumor Necrosis Factor 52 transdermal delivery 52 Targeted Chemotherapy 52 P#X# antagonist 52 Veregen TM 52 Gleevec resistant 52 fibrin derived 52 Delta opioid receptor 52 antibody fragment therapeutics 52 Exelixis compounds 52 EGF receptor 52 ZFPs 52 protein ADNP 52 novel antifolate 52 Unit Dose Budesonide 52 multitargeted 52 oral JAK1 52 mGluR4 52 selective receptor agonist 52 sumatriptan DosePro 52 Ube Industries Ltd. 52 biobetter 52 CB1 antagonists 52 proprietary transdermal 52 NEUGENE 52 commercializing anti infective 52 beta amyloid peptide 52 IMP# 52 galectin 52 Cytomegalovirus CMV 52 immunological diseases 52 azoles 52 allosteric 52 ERK1 2 52 BN# [002] 52 fusion enhancers 52 Veronate R 52 alpha 2A adrenergic 52 candidate epratuzumab 52 intranasal insulin product 52 Kissei Pharmaceutical Co. 52 PI3 kinase 52 oral PTH 52 CXCR4 receptor 52 Captisol ® 52 PARP inhibitors 52 Fx #A 52 DNA gyrase 52 kinase profiling 52 Fibroblast Growth Factor Receptor 52 TLR agonists 52 siRNA molecules 52 short interfering RNA 52 ALV# 52 superparamagnetic iron oxide nanoparticles 52 SonoPrep 52 p# inhibitors 52 GSK3B 52 immunomodulatory properties 52 telomerase inhibitor 52 Protexia ® 52 LentiVector technology 52 delipidation 52 GeneICE 51 selective inverse agonist 51 GIPET 51 ImmuneRegen Homspera 51 tubulin inhibitor 51 fusion protein 51 proteins peptides 51 molecularly targeted 51 mucosal vaccines 51 FAAH 51 agonists 51 Pentad TM 51 DUROS 51 High Impact AMPAKINE 51 NuMimetic TM 51 resolvins 51 Cardium Therapeutics TM 51 recombinant antibodies 51 alpha#beta# integrin 51 Orapred ODT 51 Anchor Therapeutics 51 Anticalin ® 51 siRNA mediated 51 Chemokine Therapeutics 51 fatty acid amide hydrolase 51 JAK3 inhibitor 51 neuro inflammatory 51 bioactive 51 muco adhesive technology 51 NPC 1C 51 Taiho Pharmaceutical 51 Phylomer ® 51 coupled receptor GPCR 51 acid phosphatase PAP 51 MP4 molecule 51 GPR# agonist 51 Captisol Enabled 51 FGFR 51 OGAP R 51 LEUKINE 51 Curaxin CBLC# 51 bioactive lipids 51 Inc. AMEX YMI 51 Gamunex C 51 commercialize AzaSite 51 Wnt signaling pathway 51 RNA interference RNAi therapeutics 51 RNAi therapeutic 51 virus AAV 51 CyDex Pharmaceuticals Inc. 51 CBLC# 51 recombinant vaccine 51 IMiDs 51 oligonucleotide 51 activity dependent neurotrophic 51 Fresenius Biotech 51 NexACT ® 51 GPR# agonists 51 ZFP TF 51 CompoZr 51 intracellular protein 51 HCV antiviral 51 Exherin TM 51 xenograft models 51 HuCAL GOLD R 51 Triphendiol 51 eligen 51 Intermezzo ® zolpidem tartrate 51 lentiviral vector 51 Aegis Therapeutics 51 Adenosine 51 Xencor XmAb 51 ChiSys 51 Crizotinib 51 ONCONASE R 51 developing Zerenex TM 51 antitumor 51 bifunctional 51 TLR7 51 antibody humanization 51 DispersinB ® 51 IKK beta 51 human parthenogenetic stem 51 Potelligent 51 Omeros Corporation 51 Amigal 51 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 51 antibiotic anti infective 51 LNP formulations 51 Galderma SA 51 Beta catenin 51 CombinatoRx Incorporated CRXX 51 TLR Therapeutics 51 vaccine adjuvant 51 BiTE R 51 Psoraxine R 51 Chipscreen 51 LPM TM 51 SMARTICLES 51 DuraSite 51 small interfering RNA 51 anti botulism antibody 51 commercialize becocalcidiol patented 51 Cx# [002] 51 biodegradable implant 51 rALLy clinical trial 51 candidate ATHX 51 UsiRNAs 51 telomerase activator 51 Aldosterone 51 investigational therapies 51 Company TAIFUN R 51 nanoemulsion 51 oncolytic virus therapies 51 ApoB SNALP 51 mAb 51 treat lupus renal 51 histone methyltransferases HMTs 51 LentiVector 51 Soliris eculizumab 51 Lipid Polymer Micelle LPM 51 Nanobodies R 51 Oxiplex 51 Tranzyme 51 CIMYM 51 Rosetta Genomics Nasdaq ROSG 51 nanoparticle formulation 51 InterfeRx 51 Fleximer R 51 fluorinated carbohydrate mimics 51 anti infective treatments 51 Scancell 51 MetAP2 51 HSP# inhibitors 51 Alzheimer disease cognitive impairment 51 commercialize Aganocides 50 Panzem 50 unoprostone isopropyl 50 Transfection Reagent 50 sd rxRNA 50 CA4P 50 pharmacokinetic properties 50 3 kinase PI3K 50 PSMA ADC 50 Symphogen